Manway Pharmaceuticals Private Limited
About Manway Pharmaceuticals Private Limited
Data last updated:
Manway Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2018PTC180181. Its GSTIN is 08AAMCM2296B1ZE (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sanjay Nagar and Ravi Kumbhakar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gat No 1005Tq Haveli Dube Nagar Wagholi, Pune, Maharashtra, India – 412207.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.3 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹18,322 (net margin -0.3%) and EBITDA of ₹1.14 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 18% over five years.
Company details
Contact details
Manway Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGat No 1005Tq Haveli Dube Nagar Wagholi, Pune, Maharashtra, India – 412207
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Manway Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Manway Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Manway Pharmaceuticals Private Limited, buy the company report.
Financials of Manway Pharmaceuticals Private Limited
FY 2025 filings availableManway Pharmaceuticals Private Limited reported revenue of ₹70.3 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 2% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.14 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹18,322 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Manway Pharmaceuticals Private Limited, buy the company report.
Board of directors of Manway Pharmaceuticals Private Limited
Manway Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Nagar | Director | 14 Nov 2018 | 7 Years 11 Months | Current |
| Ravi Kumbhakar | Director | 14 Nov 2018 | 7 Years 11 Months | Current |
| Shiv Kumar Singhal | Director | 14 Nov 2018 | 7 Years 11 Months | Current |
Auditor
Manway Pharmaceuticals Private Limited is audited by DCJ & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DCJ & ASSOCIATES | FY 2023 | 015039C |
Shareholding
The shareholding of Manway Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Manway Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Manway Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manway Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Manway Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAMCM2296B1ZE | Rajasthan | Active | 18 Dec 2018 |
To see the full GST registrations and return filing status of Manway Pharmaceuticals Private Limited, buy the company report.
Recent activity
Manway Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Ravi Kumbhakar was appointed as Director on 14 Nov 2018.
Frequently asked questions
Manway Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 November 2018 (8+ years old) and is registered under CIN U51909PN2018PTC180181.
Manway Pharmaceuticals has 3 current directors:
- Sanjay Nagar - Director
- Ravi Kumbhakar - Director
- Shiv Kumar Singhal - Director
The latest financial statements of Manway Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Manway Pharmaceuticals is 08AAMCM2296B1ZE, registered in Rajasthan.
The CIN (Corporate Identification Number) of Manway Pharmaceuticals is U51909PN2018PTC180181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manway Pharmaceuticals was incorporated on 14 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Ravi Kumbhakar was appointed as Director on 14 Nov 2018. Sanjay Nagar was appointed as Director on 14 Nov 2018. Shiv Kumar Singhal was appointed as Director on 14 Nov 2018.
The registered office of Manway Pharmaceuticals is at Gat No 1005Tq Haveli Dube Nagar Wagholi, Pune, Maharashtra, India – 412207.
Manway Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Manway Pharmaceuticals can be reached at its registered office: Gat No 1005Tq Haveli Dube Nagar Wagholi, Pune, Maharashtra, India – 412207.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
